Æå¼öŬ·çÁ¤10¹Ð¸®±×·¥(Æå¼öÇÁ¶óÀÜ¿°»ê¿°)_(10mg/1Á¤) | (ÁÖ)´ë¿õÁ¦¾à | 641607740 | Fexuprazan | 704702ATB | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
¾Û½ÃÅäÁ¤10¹Ð¸®±×·¥(Æå¼öÇÁ¶óÀÜ¿°»ê¿°)_(10mg/1Á¤) | ÇѿùÙÀÌ¿ÀÆĸ¶(ÁÖ) | 655605510 | Fexuprazan | 704702ATB | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
À§Ä¸Á¤10¹Ð¸®±×·¥(Æå¼öÇÁ¶óÀÜ¿°»ê¿°)_(10mg/1Á¤) | ´ë¿õ¹ÙÀÌ¿À(ÁÖ) | 694003860 | Fexuprazan | 704702ATB | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
ºñÁÙŸÁ¡¾È¾×0.024%(¶óŸ³ëÇÁ·Î½ºÆ¾ºÎ³ëµå)_(0.6mg/2.5mL) | (ÁÖ)¹Ù½´ÇコÄÚ¸®¾Æ | 664400301 | Latanoprostene bunod | 694601COS | 2 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ À¯»ê, ³«ÅÂ, ÅÂÀÚ ¼Õ»ó, ±âÇü °üÂûµÊ |
ºñÁÙŸÁ¡¾È¾×0.024%(¶óŸ³ëÇÁ·Î½ºÆ¾ºÎ³ëµå)_(1.2mg/5mL) | (ÁÖ)¹Ù½´ÇコÄÚ¸®¾Æ | 664400302 | Latanoprostene bunod | 694602COS | 2 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ À¯»ê, ³«ÅÂ, ÅÂÀÚ ¼Õ»ó, ±âÇü °üÂûµÊ |
·º¶óÀÚÁ¤80¹Ð¸®±×·¥(·¹ÀÌÀúƼ´Õ¸Þ½Ç»ê¿°Àϼöȹ°)_(96.48mg/1Á¤) | (ÁÖ)À¯ÇѾçÇà | 642105660 | Lazertinib | 695101ATB | 2 | 20230045 | 20230705 | ·§Æ®¿¡¼ ÅÂÀÚ Âø»ó ÈÄ ¼Õ½Ç Áõ°¡ ¹× Áß·® °¨¼Ò °üÂûµÊ |
¾ÆÁ¶ºñÇÁ¸®Çʵå½Ã¸°ÁöÁÖ(ÇÁ·¹¸¶³×ÁÖ¸¿,À¯ÀüÀÚÀçÁ¶ÇÕ)_(0.225g/1.5mL) | (ÁÖ)Çѵ¶Å×¹Ù | 626900941 | Fremanezumab | 699601BIJ | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
¾ÆÁ¶ºñ¿ÀÅäÀÎÁ§ÅÍÁÖ(ÇÁ·¹¸¶³×ÁÖ¸¿,À¯ÀüÀÚÀçÁ¶ÇÕ)_(0.225g/1.5mL) | (ÁÖ)Çѵ¶Å×¹Ù | 626900951 | Fremanezumab | 699601BIJ | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
·Ñ·ÐƼ½ºÇÁ¸®Çʵå½Ã¸°ÁöÁÖ(¿¡ÇöóÆä±×¶ó½ºÆÀ)_(3.6mg/0.6mL) | Çѹ̾àÇ°(ÁÖ) | 643508411 | Eflapegrastim | 700001BIJ | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³. Åä³¢¿¡¼ ÅÂÀÚµ¶¼º °üÂûµÊ |
½ÃºóÄÚÁ¤50¹Ð¸®±×·¥(¾Æºê·Î½ÃƼ´Õ)_(50mg/1Á¤) | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 648903630 | Abrocitinib | 703701ATB | 2 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ »ý½Äµ¶¼º, ÅÂÀÚÀÇ °ñ°Ýº¯Çü, ¹èÅÂÀÚ Ä¡»çÀ² Áõ°¡, ³»ê, üÁß°¨¼Ò, Ãâ»ý ÈÄ »ýÁ¸·ü °¨¼Ò °üÂûµÊ |
½ÃºóÄÚÁ¤200¹Ð¸®±×·¥(¾Æºê·Î½ÃƼ´Õ)_(0.2g/1Á¤) | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 648903640 | Abrocitinib | 703702ATB | 2 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ »ý½Äµ¶¼º, ÅÂÀÚÀÇ °ñ°Ýº¯Çü, ¹èÅÂÀÚ Ä¡»çÀ² Áõ°¡, ³»ê, üÁß°¨¼Ò, Ãâ»ý ÈÄ »ýÁ¸·ü °¨¼Ò °üÂûµÊ |
½ÃºóÄÚÁ¤100¹Ð¸®±×·¥(¾Æºê·Î½ÃƼ´Õ)_(0.1g/1Á¤) | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 648903650 | Abrocitinib | 703703ATB | 2 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ »ý½Äµ¶¼º, ÅÂÀÚÀÇ °ñ°Ýº¯Çü, ¹èÅÂÀÚ Ä¡»çÀ² Áõ°¡, ³»ê, üÁß°¨¼Ò, Ãâ»ý ÈÄ »ýÁ¸·ü °¨¼Ò °üÂûµÊ |
º£¸£Äíº¸Á¤5¹Ð¸®±×·¥(º£¸®½Ã±¸¾Ñ(¹ÌºÐÈ))_(5mg/1Á¤) | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 641106150 | Vericiguat | 704001ATB | 1 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ À¯»ê, Èí¼ö Áõ°¡, ½ÉÀå ¹× ÁÖ¿ä Ç÷°ü ±âÇü, »õ³¢ÀÇ Ã¼Áß Áõ°¡·® °¨¼Ò, »õ³¢ Ä¡»çÀ² Áõ°¡ °üÂûµÊ |
º£¸£Äíº¸Á¤2.5¹Ð¸®±×·¥(º£¸®½Ã±¸¾Ñ(¹ÌºÐÈ))_(2.5mg/1Á¤) | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 641106160 | Vericiguat | 704002ATB | 1 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ À¯»ê, Èí¼ö Áõ°¡, ½ÉÀå ¹× ÁÖ¿ä Ç÷°ü ±âÇü, »õ³¢ÀÇ Ã¼Áß Áõ°¡·® °¨¼Ò, »õ³¢ Ä¡»çÀ² Áõ°¡ °üÂûµÊ |
º£¸£Äíº¸Á¤10¹Ð¸®±×·¥(º£¸®½Ã±¸¾Ñ(¹ÌºÐÈ))_(10mg/1Á¤) | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 641106170 | Vericiguat | 704003ATB | 1 | 20230045 | 20230705 | µ¿¹°½ÇÇè¿¡¼ À¯»ê, Èí¼ö Áõ°¡, ½ÉÀå ¹× ÁÖ¿ä Ç÷°ü ±âÇü, »õ³¢ÀÇ Ã¼Áß Áõ°¡·® °¨¼Ò, »õ³¢ Ä¡»çÀ² Áõ°¡ °üÂûµÊ |
Å´¸®¾ÆÁÖ(Ƽ»çÁ¨·º·ù¼¿) | Çѱ¹³ë¹ÙƼ½º(ÁÖ) | 653603381 | Tisagenlecleucel | 706201BIJ | 2 | 20230045 | 20230705 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
Æ÷½ºÄ«ºñ¾îÁÖ(Æ÷½ºÄ«³×Æ®³ªÆ®·ý¼öȹ°)_(6g/250mL) | Ŭ¸®´ÏÁ¨ÄÚ¸®¾Æ(À¯) | 076100041 | foscarnet | 632330BIJ | 2 | 20220049 | 20220630 | ·§Æ®¿¡¼ ÅÂ¹Ý Åë°ú º¸°í |
ºí¸°»çÀÌÅäÁÖ35¸¶ÀÌÅ©·Î±×·¥(ºí¸®³ªÅõ¸ð¸¿, À¯ÀüÀÚÀçÁ¶ÇÕ)_(38.5¥ìg/1º´) | ¾ÏÁ¨ÄÚ¸®¾ÆÀ¯ÇÑȸ»ç | 052300031 | blinatumomab | 647701BIJ | 2 | 20220049 | 20220630 | ÀӺο¡ ´ëÇÑ ¾ÈÀü¼º ¹ÌÈ®¸³ |
Å©¸®ÇȽºÁ¤0.5¹Ð¸®±×·¥(¹Ù·¹´ÏŬ¸°»ì¸®½Ç»ê¿°)_(0.825mg/1Á¤) | Å©¸®½ºÅ»»ý¸í°úÇÐ(ÁÖ) | 052701250 | varenicline | 673101ATB | 2 | 20220049 | 20220630 | µ¿¹° ½ÃÇè¿¡¼ »ý½Äµ¶¼ºÀÌ ³ªÅ¸³² |
ÁßÇå¹Ù·¹´ÏŬ¸°»ì¸®½Ç»ê¿°Á¤0.5¹Ð¸®±×·¥_(0.825mg/1Á¤) | (ÁÖ)ÁßÇåÁ¦¾à | 053300990 | varenicline | 673101ATB | 2 | 20220049 | 20220630 | µ¿¹° ½ÃÇè¿¡¼ »ý½Äµ¶¼ºÀÌ ³ªÅ¸³² |